Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-05-16 Sale |
2023-05-18 5:18 pm |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director |
4,444 | $77.2 | $343,081 | 38,488 (Direct) |
View |
| 2023-05-10 Sale |
2023-05-12 3:43 pm |
LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director |
6,408 | $77.13 | $494,225 | 26,711 (Direct) |
View |
| 2023-05-08 Sale |
2023-05-10 7:15 pm |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director |
6,408 | $76.56 | $490,628 | 42,213 (Direct) |
View |
| 2023-03-24 Sale |
2023-03-28 5:00 pm |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew See Remarks |
300 | $69.92 | $20,977 | 16,308 (Direct) |
View |
| 2022-12-16 Sale |
2022-12-20 6:36 pm |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Director |
10,000 | $61.87 | $618,657 | 422,984 (Direct) |
View |
| 2022-12-12 Sale |
2022-12-14 5:00 pm |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Director |
3,944 | $64.8 | $255,571 | 453,319 (Direct) |
View |
| 2022-11-17 Sale |
2022-11-21 7:04 pm |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
10,000 | $78.32 | $783,173 | 467,066 (Direct) |
View |
| 2022-11-09 Sale |
2022-11-10 4:30 pm |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
1,696 | $75.64 | $128,283 | 8,857 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-09 Option Award |
2023-06-13 6:55 pm |
N/A 2033-06-09 |
LIGAND PHARMACEUTICALS INC | LGND | Gray Nancy Ryan Director |
6,603 | $0 | 12,028 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 6:55 pm |
N/A 2033-06-09 |
LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director |
6,603 | $0 | 33,724 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 6:54 pm |
N/A 2033-06-09 |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director |
6,603 | $0 | 45,091 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 6:54 pm |
N/A 2033-06-09 |
LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director |
6,603 | $0 | 133,609 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 6:53 pm |
N/A 2033-06-09 |
LIGAND PHARMACEUTICALS INC | LGND | Haas Jason Director |
6,603 | $0 | 9,606 (Direct) |
View |
| 2023-06-09 Tax Withholding |
2023-06-13 6:52 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C CHIEF EXECUTIVE OFFICER |
420 | $73.76 | 69,090 (Direct) |
View |
| 2023-05-10 Exercise |
2023-05-12 3:43 pm |
N/A 2023-06-11 |
LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director |
6,408 | $0 | 26,711 (Direct) |
View |
| 2023-05-08 Exercise |
2023-05-10 7:15 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director |
6,408 | $18.82 | 42,213 (Direct) |
View |
| 2023-05-08 Exercise |
2023-05-10 7:15 pm |
N/A 2023-06-11 |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director |
6,408 | $0 | 42,213 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 8:54 pm |
N/A 2033-02-23 |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
22,465 | $0 | 40,561 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 8:52 pm |
N/A 2033-02-23 |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
33,697 | $0 | 123,376 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 8:51 pm |
N/A 2033-02-23 |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew See Remarks |
21,061 | $0 | 32,001 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 8:50 pm |
N/A 2033-02-23 |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
63,183 | $0 | 114,969 (Direct) |
View |
| 2023-02-15 Tax Withholding |
2023-02-17 7:23 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
2,890 | $72.98 | 89,679 (Direct) |
View |
| 2023-02-15 Tax Withholding |
2023-02-17 7:20 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
849 | $72.98 | 18,096 (Direct) |
View |
| 2022-12-30 Other |
2023-01-04 5:00 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
275 | $56.78 | 19,220 (Direct) |
View |
| 2022-12-28 Tax Withholding |
2022-12-30 5:00 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
3,859 | $66.29 | 92,569 (Direct) |
View |
| 2022-12-28 Tax Withholding |
2022-12-30 5:00 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Director |
5,289 | $66.29 | 417,695 (Direct) |
View |
| 2022-12-22 Option Award |
2022-12-27 6:37 pm |
N/A 2024-12-05 |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Director |
92,932 | $0 | 92,932 (Direct) |
View |
| 2022-12-22 Option Award |
2022-12-27 6:34 pm |
N/A 2032-12-22 |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
25,967 | $0 | 25,967 (Direct) |
View |
| 2022-12-22 Option Award |
2022-12-27 6:31 pm |
N/A 2032-12-22 |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director |
6,623 | $0 | 6,623 (Direct) |
View |
| 2022-12-22 Option Award |
2022-12-27 6:31 pm |
N/A 2032-12-22 |
LIGAND PHARMACEUTICALS INC | LGND | Gray Nancy Ryan Director |
3,050 | $0 | 3,050 (Direct) |
View |
| 2022-12-22 Option Award |
2022-12-27 6:30 pm |
N/A 2032-12-22 |
LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director |
6,623 | $0 | 6,623 (Direct) |
View |
| 2022-12-22 Option Award |
2022-12-27 6:28 pm |
N/A 2032-12-22 |
LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director |
4,484 | $0 | 4,484 (Direct) |
View |
| 2022-12-22 Option Award |
2022-12-27 6:26 pm |
N/A 2032-12-22 |
LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director |
4,484 | $0 | 4,484 (Direct) |
View |
| 2022-12-22 Option Award |
2022-12-27 6:26 pm |
N/A 2032-12-22 |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
2,081 | $0 | 2,081 (Direct) |
View |
| 2022-12-22 Option Award |
2022-12-27 6:26 pm |
N/A 2032-12-22 |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
6,620 | $0 | 6,620 (Direct) |
View |
| 2022-12-13 Option Award |
2022-12-15 6:17 pm |
N/A 2032-12-13 |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
44,000 | $0 | 126,428 (Direct) |
View |
| 2022-12-13 Option Award |
2022-12-15 6:13 pm |
N/A 2032-12-13 |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
31,000 | $0 | 38,670 (Direct) |
View |
| 2022-12-12 Exercise |
2022-12-14 5:00 pm |
N/A 2023-02-15 |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Director |
20,000 | $0 | 453,319 (Direct) |
View |
| 2022-12-12 Exercise |
2022-12-14 5:00 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Director |
20,000 | $12.78 | 453,319 (Direct) |
View |
| 2022-12-05 Option Award |
2022-12-06 8:25 pm |
N/A 2032-12-05 |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Chief Executive Officer |
132,000 | $0 | 132,000 (Direct) |
View |
| 2022-11-30 Tax Withholding |
2022-12-01 9:42 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E President & COO |
3,593 | $72.9 | 82,428 (Direct) |
View |
| 2022-11-30 Tax Withholding |
2022-12-01 9:42 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
9,803 | $72.9 | 416,928 (Direct) |
View |
| 2022-11-30 Tax Withholding |
2022-12-01 9:41 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Espinoza Octavio Chief Financial Officer |
1,187 | $72.9 | 7,670 (Direct) |
View |
| 2022-11-30 Tax Withholding |
2022-12-01 9:39 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Reardon Andrew See Remarks |
1,073 | $72.9 | 10,940 (Direct) |
View |
| 2022-11-18 Exercise |
2022-11-21 7:04 pm |
N/A 2023-02-15 |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
10,000 | $0 | 467,066 (Direct) |
View |
| 2022-11-18 Exercise |
2022-11-21 7:04 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
10,000 | $12.78 | 467,066 (Direct) |
View |